Page last updated: 2024-08-17

lactose and Pancreatic Neoplasms

lactose has been researched along with Pancreatic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Djaker, N; Khan, M; Li, X; Liu, H; Marsich, E; Sacco, P; Spadavecchia, J1
Alauddin, MM; Gelovani, JG; Turkman, N1
Alauddin, MM; De Palatis, L; Paolillo, V1
Chan, JM; Holly, EA; Wang, F1
Alauddin, MM; Bertolini, S; Bornmann, W; Flores, LG; Gelovani, JG; Logsdon, C; Mukhopadhyay, U; Pal, A; Shavrin, A; Soghomonyan, S; Tong, W; Volgin, A; Yeh, HH; Ying, Y; Young, D1
Alauddin, MM; Bertolini, S; Bornmann, W; Flores, LG; Gelovani, JG; Ghosh, P; Guo, L; Logsdon, C; Mukhapadhyay, U; Pal, A; Peng, Z; Soghomonyan, S; Volgin, A; Yeh, HH; Ying, Y; Young, D1

Other Studies

6 other study(ies) available for lactose and Pancreatic Neoplasms

ArticleYear
DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.
    International journal of nanomedicine, 2022, Volume: 17

    Topics: Animals; Chitosan; Cholangiocarcinoma; Contrast Media; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lactose; Meglumine; Metal Nanoparticles; Mice; Organometallic Compounds; Pancreatic Neoplasms; Polymers

2022
An improved synthesis of 1'-[18F]fluoroethyl-β-D-lactose ([18F]-FEL) for positron emission tomography imaging of pancreatic cancer.
    Journal of labelled compounds & radiopharmaceuticals, 2013, Jun-15, Volume: 56, Issue:7

    Topics: Carcinoma; Humans; Lactose; Pancreatic Neoplasms; Pancreatitis-Associated Proteins; Positron-Emission Tomography; Radiopharmaceuticals

2013
Optimization of precursor synthesis, formulation and stability of 1'-[18F]fluoroethyl-β-D-lactose ([18F]FEL) for preclinical studies in detection of pancreatic cancer.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:4

    Topics: Chemistry Techniques, Synthetic; Chemistry, Pharmaceutical; Drug Stability; Lactose; Pancreatic Neoplasms; Positron-Emission Tomography

2014
Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study.
    Cancer causes & control : CCC, 2009, Volume: 20, Issue:6

    Topics: Adenocarcinoma; California; Carbonated Beverages; Case-Control Studies; Confidence Intervals; Female; Humans; Incidence; Interviews as Topic; Lactose; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Pancreatic Neoplasms; Risk Factors; SEER Program; Sex Factors; Sweetening Agents

2009
Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT.
    PloS one, 2009, Nov-24, Volume: 4, Issue:11

    Topics: Animals; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma; Carcinoma, Acinar Cell; Fluorine Radioisotopes; Lactose; Lectins, C-Type; Ligands; Mice; Models, Biological; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; Pancreatitis-Associated Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2009
Synthesis and ex vivo autoradiographic evaluation of ethyl-β-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[18F]fluoro-β-D-glucopyranoside--a novel radioligand for lactose-binding protein: implications for early detection of pancreatic carcinomas with PET.
    Molecular imaging and biology, 2011, Volume: 13, Issue:3

    Topics: Animals; Antigens, Neoplasm; Autoradiography; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Disaccharides; Early Detection of Cancer; Glucosides; Halogenation; Immunohistochemistry; Lactose; Lectins, C-Type; Ligands; Mice; Neoplasm Proteins; Pancreatic Neoplasms; Pancreatitis-Associated Proteins; Positron-Emission Tomography; Radiopharmaceuticals

2011